{"id":"W2152727843","doi":"10.1056/nejmoa0809335","title":"A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":891,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"UCB Pharma; Technion-Israel Institute of Technology; Eisai; H. Lundbeck A/S; Teva Pharmaceutical Industries; AstraZeneca","keywords":"Rasagiline; Medicine; Placebo; Parkinson's disease; Rating scale; Clinical trial; Internal medicine; Disease; Psychology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008090503,0.0002259433,0.0008616557,0.0004741815,0.00002623973,0.000005443268,0.000130735,0.00007483128,0.0002265916],"category_scores_gemma":[0.0002482491,0.0001467502,0.0001842021,0.0003326377,0.00005824474,0.0001072378,0.00001218059,0.0003100881,0.000003627491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008108887,"about_ca_system_score_gemma":0.0004736699,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007596999,"about_ca_topic_score_gemma":0.00002507062,"domain_scores_codex":[0.9977739,0.00007943986,0.0009100126,0.0001963134,0.0007713325,0.0002689555],"domain_scores_gemma":[0.9981216,0.00009438679,0.0004689053,0.0002620778,0.0001932849,0.0008597006],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8753862,0.002125735,0.00747838,0.00004791938,0.0002626975,0.003460108,0.000400626,0.00004516904,0.001670321,0.0003167214,0.00272075,0.1060854],"study_design_scores_gemma":[0.8932276,0.01004594,0.02395982,0.0006572942,0.0007833219,0.0002708416,0.0000603007,0.00007418566,0.0004869079,0.001695378,0.06861871,0.0001196946],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853075,0.003722132,0.0003077078,0.008906713,0.000510779,0.0005336238,0.00000750446,0.00001117768,0.0006928874],"genre_scores_gemma":[0.9949367,0.0009706896,0.0005157598,0.0006103014,0.002587332,0.000003307661,0.00002341861,0.00001586531,0.0003366349],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1059657,"threshold_uncertainty_score":0.5984298,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03841160269892531,"score_gpt":0.3158439581302381,"score_spread":0.2774323554313128,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}